HCM vs. ASHR
HCM (HUTCHMED (China) Limited) is a stock, while ASHR (Xtrackers Harvest CSI 300 China A-Shares ETF) is China Equities fund tracking the CSI 300 Index. Over the past 10 years, HCM returned -2.60%/yr vs 5.96%/yr for ASHR. At a 0.30 correlation, their price movements are largely independent.
Performance
HCM vs. ASHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HCM achieves a -23.78% return, which is significantly lower than ASHR's 9.77% return. Over the past 10 years, HCM has underperformed ASHR with an annualized return of -2.60%, while ASHR has yielded a comparatively higher 5.96% annualized return.
HCM
- 1D
- 1.70%
- 1M
- -15.26%
- YTD
- -23.78%
- 6M
- -24.63%
- 1Y
- -33.20%
- 3Y*
- -1.96%
- 5Y*
- -20.31%
- 10Y*
- -2.60%
ASHR
- 1D
- -3.32%
- 1M
- 2.01%
- YTD
- 9.77%
- 6M
- 10.21%
- 1Y
- 37.51%
- 3Y*
- 12.76%
- 5Y*
- -0.54%
- 10Y*
- 5.96%
HCM vs. ASHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HCM HUTCHMED (China) Limited | -23.78% | -7.49% | -20.43% | 22.53% | -57.87% | 9.56% | 27.72% | 8.58% | -41.43% | 190.49% |
ASHR Xtrackers Harvest CSI 300 China A-Shares ETF | 9.77% | 27.02% | 11.95% | -12.52% | -27.52% | -1.57% | 36.29% | 36.50% | -28.45% | 33.47% |
Correlation
The correlation between HCM and ASHR is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Mar 17, 2016 | 0.30 |
The correlation between HCM and ASHR shifts across timeframes, from 0.25 (1 year) to 0.37 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HCM vs. ASHR — Risk / Return Rank
HCM
ASHR
HCM vs. ASHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for HUTCHMED (China) Limited (HCM) and Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HCM | ASHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.02 | ||
| Sortino ratioReturn per unit of downside risk | -4.18 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.37 | -0.52 |
| Calmar ratioReturn relative to maximum drawdown | -0.69 | 4.90 | -5.59 |
| Martin ratioReturn relative to average drawdown | -1.35 | 14.20 | -15.55 |
Loading charts...
Drawdowns
HCM vs. ASHR - Drawdown Comparison
The maximum HCM drawdown since its inception was -82.18%, which is greater than ASHR's maximum drawdown of -51.30%. Use the drawdown chart below to compare losses from any high point for HCM and ASHR.
Loading charts...
Drawdown Indicators
| HCM | ASHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.18% | -51.30% | -30.88% |
Max Drawdown (1Y)Largest decline over 1 year | -48.00% | -7.69% | -40.31% |
Max Drawdown (3Y)Largest decline over 3 years | -54.13% | -33.12% | -21.01% |
Max Drawdown (5Y)Largest decline over 5 years | -82.18% | -44.59% | -37.59% |
Max Drawdown (10Y)Largest decline over 10 years | -82.18% | -51.30% | -30.88% |
Current DrawdownCurrent decline from peak | -76.34% | -15.89% | -60.45% |
Average DrawdownAverage peak-to-trough decline | -40.31% | -29.13% | -11.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.59% | 2.65% | +21.94% |
Volatility
HCM vs. ASHR - Volatility Comparison
HUTCHMED (China) Limited (HCM) has a higher volatility of 9.35% compared to Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) at 7.31%. This indicates that HCM's price experiences larger fluctuations and is considered to be riskier than ASHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HCM | ASHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.35% | 7.31% | +2.04% |
Volatility (6M)Calculated over the trailing 6-month period | 23.48% | 12.95% | +10.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.60% | 17.88% | +18.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.61% | 24.01% | +41.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.34% | 24.09% | +35.25% |
Dividends
HCM vs. ASHR - Dividend Comparison
HCM has not paid dividends to shareholders, while ASHR's dividend yield for the trailing twelve months is around 2.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASHR Xtrackers Harvest CSI 300 China A-Shares ETF | 2.10% | 2.31% | 1.13% | 2.48% | 1.13% | 0.88% | 0.81% | 0.98% | 1.32% | 0.84% | 0.73% | 30.13% |
HCM HUTCHMED (China) Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HCM and ASHR have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HCM has higher volatility (9.35%) compared to ASHR (7.31%). In terms of maximum drawdown, HCM dropped -82.18% vs ASHR's -51.30%.
ASHR currently has the higher Sharpe Ratio (2.11 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HCM and ASHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer